Global Warts Therapeutics Market, 2021-2027

January 2022 | 79 pages | ID: GA75319947FCEN
Gen Consulting Company

Abstracts

Warts are a type of skin infection caused by the human papillomavirus (HPV). The infection causes rough, skin-colored bumps to form on the skin. The global warts therapeutics market was estimated at USD 1,879 million in 2020 and is expected to hit USD 2,540 million by 2027, registering a CAGR of 4.4% from 2021 to 2027 as per the latest report by Gen Consulting Company.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global warts therapeutics market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments.

The warts therapeutics market is segmented on the basis of type, treatment, end user, and region. The warts therapeutics market is segmented as below:

By type:

• common warts
• genital warts
• flat warts
• others

By treatment:

• physical destruction (cryotherapy, surgical removal, laser treatment)
• immunomodulation (interferons, retinoids, zinc)
• chemical destruction (bleomycin, cantharidin, salicylic acid, others)

By end user:

• hospitals
• homecare
• specialty clinics
• others

By region:

• region
• Asia Pacific
• Europe
• North America
• Rest of the World (RoW)

The report also provides a detailed analysis of several leading warts therapeutics market vendors that include Bausch Health Companies Inc., Cipla Limited, Euro Vital Pharma GmbH, GlaxoSmithKline plc, Koninklijke Utermohlen NV, Nielsen BioSciences, Inc., Novan, Inc., Scholl’s Wellness Company LLC, Teva Pharmaceutical Industries Ltd., among others.

*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period

This research report provides analysis for each segment from 2017 to 2027 considering 2020 to be the base year.

Scope of the Report

• To analyze and forecast the market size of the global warts therapeutics market.
• To classify and forecast the global warts therapeutics market based on type, treatment, end user, and region.
• To identify drivers and challenges for the global warts therapeutics market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global warts therapeutics market.
• To identify and analyze the profile of leading players operating in the global warts therapeutics market.

Why Choose This Report

• Gain a reliable outlook of the global warts therapeutics market forecasts from 2021 to 2027 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.

Contents

PART 1. INTRODUCTION

1.1 Market definition
1.2 Key benefits
1.3 Market segment

PART 2. METHODOLOGY

2.1 Primary
2.2 Secondary

PART 3. EXECUTIVE SUMMARY

PART 4. MARKET OVERVIEW

4.1 Introduction
4.2 Market dynamics
  4.2.1 Drivers
  4.2.2 Restraints

PART 5. GLOBAL MARKET FOR WARTS THERAPEUTICS BY TYPE

5.1 Common warts
  5.1.1 Market size and forecast
5.2 Genital warts
  5.2.1 Market size and forecast
5.3 Flat warts
  5.3.1 Market size and forecast
5.4 Others
  5.4.1 Market size and forecast

PART 6. GLOBAL MARKET FOR WARTS THERAPEUTICS BY TREATMENT

6.1 Physical destruction (cryotherapy, surgical removal, laser treatment)
  6.1.1 Market size and forecast
6.2 Immunomodulation (interferons, retinoids, zinc)
  6.2.1 Market size and forecast
6.3 Chemical destruction (bleomycin, cantharidin, salicylic acid, others)
  6.3.1 Market size and forecast

PART 7. GLOBAL MARKET FOR WARTS THERAPEUTICS BY END USER

7.1 Hospitals
  7.1.1 Market size and forecast
7.2 Homecare
  7.2.1 Market size and forecast
7.3 Specialty clinics
  7.3.1 Market size and forecast
7.4 Others
  7.4.1 Market size and forecast

PART 8. GLOBAL MARKET FOR WARTS THERAPEUTICS BY REGION

8.1 Asia Pacific
  8.1.1 Market size and forecast
8.2 Europe
  8.2.1 Market size and forecast
8.3 North America
  8.3.1 Market size and forecast
8.4 Rest of the World (RoW)
  8.4.1 Market size and forecast

PART 9. KEY COMPETITOR PROFILES

9.1 Bausch Health Companies Inc.
9.2 Cipla Limited
9.3 Euro Vital Pharma GmbH
9.4 GlaxoSmithKline plc
9.5 Koninklijke Utermohlen NV
9.6 Nielsen BioSciences, Inc.
9.7 Novan, Inc.
9.8 Scholl’s Wellness Company LLC
9.9 Teva Pharmaceutical Industries Ltd.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

DISCLAIMER

ABOUT GEN CONSULTING COMPANY